Data Foundry

Drug recalls 2014

Hydromorphone Hydrochloride Injection — Class II drug recall D-0044-2015

Terminated recall by Hospira Inc., reported 2014-10-29, distributed nationwide. Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be bro

Recall numberD-0044-2015
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmHospira Inc., Lake Forest, IL, United States
Recall initiated2014-10-01
Classified2014-10-23
Reported by FDA2014-10-29
Terminated2017-03-23
DistributedNationwide (US)
Quantity145,600 vials
Reason classesforeign material, sterility, packaging
NDC00409-2634, 00409-2634-01, 00409-2634-05, 00409-2634-10, 00409-2634-25, 00409-2634-50, 00703-0018, 00703-0018-01, 00703-0110, 00703-0110-01, 00703-0110-03, 00703-0113, 00703-0113-01, 00703-0113-03
Expiration dates2014-12-01, 2015-01-01, 2015-02-01, 2015-05-01

Product

Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packaged in a) 1 mL Single-dose Vial (NDC 0703-0110-01), packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0703-0110-03); Mfd By: Hospira Inc., Lake Forest, IL 60045; Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618; and b) 1 mL Single-dose Vial, packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0409-2634-01), Hospira, Inc., Lake Forest, IL 60045.

Reason for recall

Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0044-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.